Molecular Subsets of Mantle Cell Lymphoma Defined by the <i>IGHV</i> Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Alba Navarro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Elı́as Campo(Hospital Clínic de Barcelona), Guillem Clot(Aristotle University of Thessaloniki), Alejandra Martínez‐Trillos(Aristotle University of Thessaloniki), Andreas Agathangelidis(Aristotle University of Thessaloniki), Maria Carmela Vegliante(Aristotle University of Thessaloniki), Armando López‐Guillermo(Barcelona Supercomputing Center), Wendy N. Erber(The University of Western Australia), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Adrian Wiestner(National Institutes of Health), Reiner Siebert(Christian-Albrechts-Universität zu Kiel), Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Nikos Darzentas(Central European Institute of Technology), Nicola Trim(Aristotle University of Thessaloniki), Birgitta Sander(Karolinska University Hospital), Wyndham H. Wilson(National Institutes of Health), Eva Giné(Aristotle University of Thessaloniki), Lenka Štefančíková(Aristotle University of Thessaloniki), Itziar Salaverría(Centro de Investigación Biomédica en Red de Cáncer), Xavier Puig(Aristotle University of Thessaloniki), Magda Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Cristina Royo(Aristotle University of Thessaloniki), Sı́lvia Beà(Departament de Salut), Virgina Amador(Aristotle University of Thessaloniki), Dolors Colomer(Hospital Clínic de Barcelona), Jara Palomero(Aristotle University of Thessaloniki), Marı́a José Calasanz(Navarre Institute of Health Research), Theodora Papadaki(Aristotle University of Thessaloniki), Vasilis Bikos(Aristotle University of Thessaloniki), Anastasia Hadzidimitriou(Aristotle University of Thessaloniki), Christiane Pott(University Hospital Schleswig-Holstein), Pedro Jares(Hospital Clínic de Barcelona)
Cited by 252
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k